난소-자궁부속기 종괴: 다중기법 MR 영상의 임상 적용과 O-RADS MRI = Adnexal Masses: Clinical Application of Multiparametric MR Imaging & O-RADS MRI

국문 초록 (Abstract)

초음파에서 우연히 접하는 자궁부속기 병변은 양성 병변이 더 흔하지만, 일부는 악성도가 애매한 병변으로 간주되어 추가적인 평가를 위해 다중매개변수 MRI가 필요하다. 고식적 MRI 를 통해 해부학적 모양을 살피고, 지방, 출혈, 섬유성 조직, 고형성 조직 등 병변의 구성성분을 파악하여 많은 양성 종괴들을 정확하게 진단할 수 있다. 또한 추가적인 확산강조영상과역동적 조영증강 기법의 관류영상으로 양성과 악성의 감별 진단 정확도를 높일 수 있다. 최근 자궁부속기 종괴의 악성 위험도를 평가하고, 각 위험도 군에 대한 적절한 조치를 권고하는데 있어 표준화된 의사소통이 가능하도록 하기 위해 난소-자궁부속기 MRI 보고 및 자료시스템(ovarian-adnexal reporting and data system MRI; 이하 O-RADS MRI)이 발표되었다. 본 종설에서는 자궁부속기 종괴의 악성도 예측 및 감별 진단을 위한 다중매개변수 MRI 의 임상 적용과 O-RADS MRI에 대하여 기술하고자 한다.

다국어 초록 (Multilingual Abstract)

Incidental adnexal masses considered indeterminate for malignancy are commonly observed on ultrasonography. Multiparametric MRI is the imaging modality of choice for the evaluation of sonographically indeterminate adnexal masses. Conventional MRI enables a confident pathologic diagnosis of various benign lesions due to accurate tissue characterization of fat, blood, fibrous tissue, and solid components. Additionally, functional imaging sequences, including perfusion- and diffusion-weighted imaging, improve the diagnostic efficacy of conventional MRI in differentiating benign from malignant adnexal masses. The ovarian-adnexal reporting and data system (O-RADS) MRI was recently designed to provide consistent interpretations in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. In this review, we describe the clinical application of multiparametric MRI for the evaluation of adnexal masses and introduce the O-RADS MRI risk stratification system.

참고문헌 (Reference)

1 Michielsen K, "Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer : a clinical feasibility study in comparison to CT and FDG-PET/CT" 24 : 889-901, 2014

2 Basha MAA, "Validity and reproducibility of the ADNEX MR scoring system in the diagnosis of sonographically indeterminate adnexal masses" 53 : 292-304, 2021

3 Van Calster B, "Triaging women with ovarian masses for surgery : observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis(IOTA)group protocol" 119 : 662-671, 2012

4 Timmerman D, "Terms, definitions and measurements to describe the sonographic features of adnexal tumors : a consensus opinion from the International Ovarian Tumor Analysis(IOTA)Group" 16 : 500-505, 2000

5 Meys EM, "Subjective assessment versus ultrasound models to diagnose ovarian cancer : a systematic review and meta-analysis" 58 : 17-29, 2016

6 Rockall AG, "Role of imaging in fertility-sparing treatment of gynecologic malignancies" 36 : 2214-2233, 2016

7 Sharma A, "Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses : a prospective cohort study within the UK collaborative trial of ovarian cancer screening(UKCTOCS)" 40 : 338-344, 2012

8 Froyman W, "Risk of complications in patients with conservatively managed ovarian tumours(IOTA5) : a 2-year interim analysis of a multicentre, prospective, cohort study" 20 : 448-458, 2019

9 Carter JS, "Quantitative multiparametric MRI of ovarian cancer" 38 : 1501-1509, 2013

10 Li HM, "Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors" 43 : 3132-3141, 2018

11 Thomassin-Naggara I, "Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses : a preliminary study" 22 : 738-745, 2012

12 Greenlee RT, "Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial" 202 : 373-, 2010

13 Rizzo S, "Pre-operative evaluation of epithelial ovarian cancer patients : role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study" 123 : 108786-, 2020

14 Duarte AL, "Pitfalls of diffusion-weighted imaging of the female pelvis" 51 : 37-44, 2018

15 장건호, "Perfusion Magnetic Resonance Imaging: A Comprehensive Update on Principles and Techniques" 대한영상의학회 15 (15): 554-577, 2014

16 Anthoulakis C, "Pelvic MRI as the"gold standard"in the subsequent evaluation of ultrasoundindeterminate adnexal lesions : a systematic review" 132 : 661-668, 2014

17 Sadowski EA, "Ovary : MRI characterisation and ORADS MRI" 94 : 20210157-, 2021

18 Thomassin-Naggara I, "Ovarianadnexal reporting data system magnetic resonance imaging(O-RADS MRI)score for risk stratification of sonographically indeterminate adnexal masses" 3 : e1919896-, 2020

19 van Nagell JR Jr, "Ovarian cancer screening with annual transvaginal sonography : findings of 25, 000 women screened" 109 : 1887-1896, 2007

20 Buys SS, "Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian(PLCO)cancer screening trial : findings from the initial screen of a randomized trial" 193 : 1630-1639, 2005

21 Jacobs IJ, "Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening(UKCTOCS) : a randomised controlled trial" 387 : 945-956, 2016

22 Wu TT, "Magnetic resonance imaging of ovarian cancer arising in endometriomas" 28 : 836-838, 2004

23 Busard MP, "Magnetic resonance imaging in the evaluation of(deep infiltrating)endometriosis : the value of diffusion-weighted imaging" 31 : 1117-1123, 2010

24 Siegelman ES, "MR imaging of endometriosis : ten imaging pearls" 32 : 1675-1691, 2012

25 Masch WR, "MR imaging for incidental adnexal mass characterization" 25 : 521-543, 2017

26 Kinkel K, "Indeterminate ovarian mass at US : incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis" 236 : 85-94, 2005

27 Sadowski EA, "Indeterminate adnexal cysts at US : prevalence and characteristics of ovarian cancer" 287 : 1041-1049, 2018

28 Pereira PN, "Improving the performance of IOTA simple rules: sonographic assessment of adnexal masses with resource-effective use of a magnetic resonance scoring (ADNEX MR scoring system)" 45 : 3218-3229, 2020

29 Mohaghegh P, "Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques" 32 : 1751-1773, 2012

30 Basha MAA, "Gynecology imaging reporting and data system(GI-RADS) : diagnostic performance and inter-reviewer agreement" 29 : 5981-5990, 2019

31 Thoeny HC, "Genitourinary applications of diffusion-weighted MR imaging in the pelvis" 263 : 326-342, 2012

32 McEvoy SH, "Fertility-sparing for young patients with gynecologic cancer: how MRI can guide patient selection prior to conservative management" 42 : 2488-2512, 2017

33 Ruiz M, "External validation of the MR imaging scoring system for the management of adnexal masses" 205 : 115-119, 2016

34 Sasaguri K, "External validation of ADNEX MR SCORING system : a single-centre retrospective study" 74 : 131-139, 2019

35 Meys EMJ, "Estimating risk of malignancy in adnexal masses : external validation of the ADNEX model and comparison with other frequently used ultrasound methods" 49 : 784-792, 2017

36 Bernardin L, "Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses : radiological and pathological correlation" 22 : 880-890, 2012

37 Buys SS, "Effect of screening on ovarian cancer mortality : the prostate, lung, colorectal and ovarian(PLCO)cancer screening randomized controlled trial" 305 : 2295-2303, 2011

38 Thomassin-Naggara I, "Dynamic contrast-enhanced magnetic resonance imaging : a useful tool for characterizing ovarian epithelial tumors" 28 : 111-120, 2008

39 Oh JW, "Diffusion-weighted MRI of epithelial ovarian cancers : correlation of apparent diffusion coefficient values with histologic grade and surgical stage" 84 : 590-595, 2015

40 Li W, "Diffusion-weighted MRI : a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components" 37 : 897-903, 2012

41 Davarpanah AH, "Diffusion MRI of uterine and ovarian masses: identifying the benign lesions" 41 : 2466-2475, 2016

42 Michielsen K, "Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer" 83 : 88-98, 2017

43 Fujii S, "Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions" 28 : 1149-1156, 2008

44 Ha HK, "Diagnosis of pelvic endometriosis: fat-suppressed T1-weighted vs conventional MR images" 163 : 127-131, 1994

45 Imaoka I, "Developing an MR imaging strategy for diagnosis of ovarian masses" 26 : 1431-1448, 2006

46 Thomassin-Naggara I, "Contribution of diffusionweighted MR imaging for predicting benignity of complex adnexal masses" 19 : 1544-1552, 2009

47 Hricak H, "Complex adnexal masses : detection and characterization with MR imaging--multivariate analysis" 214 : 39-46, 2000

48 Thomassin-Naggara I, "Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging" 258 : 793-803, 2011

49 Bammer R, "Basic principles of diffusion-weighted imaging" 45 : 169-184, 2003

50 American College of Radiology, "American College of Radiology Committee on O-RADS. O-RADS MR Risk Stratification System Table 2020"

51 Hermans AJ, "Adnexal masses in children, adolescents and women of reproductive age in the Netherlands : a nationwide population-based cohort study" 143 : 93-97, 2016

52 Baser E, "Adnexal masses encountered during cesarean delivery" 123 : 124-126, 2013

53 Thomassin-Naggara I, "Adnexal masses : development and preliminary validation of an MR imaging scoring system" 267 : 432-443, 2013